Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shing M Lee

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Journal of Biopharmaceutical Statistics|September 15, 2020
A simulation study of approaches for handling disease progression in dose-finding clinical trialsLucie Biard, Bin Cheng, Gulam A Manji, et al.
Clinical Trials (London, England)|April 9, 2024
Dose optimization for cancer treatments with considerations for late-onset toxicitiesLucie Biard, Anaïs Andrillon, Rebecca B Silva, et al.
Biostatistics (Oxford, England)|November 16, 2017
Dose-finding designs for cumulative toxicities using multiple constraintsShing M Lee, Moreno Ursino, Ying Kuen Cheung, et al.
Journal of Refractive Surgery (Thorofare, N.J. : 1995)|December 7, 2005
The effect of lubricant eye drops on ocular wavefront aberrationsSuzanna Airiani, Joshua Rozell, Shing M Lee, et al.
JCO Precision Oncology|July 12, 2021
Would the Recommended Dose Have Been Different Using Novel Dose-Finding Designs? Comparing Dose-Finding Designs in Published TrialsRebecca B Silva, Christina Yap, Richard Carvajal, et al.
American Journal of Ophthalmology|July 4, 2006
Evaluating central corneal thickness measurements with noncontact optical low-coherence reflectometry and contact ultrasound pachymetrySuzanna Airiani, Stephen L Trokel, Shing M Lee, et al.
Statistics in Medicine|October 31, 2024
Dose Individualization for Phase I Cancer Trials With Broadened EligibilityRebecca B Silva, Bin Cheng, Richard D Carvajal, et al.
JCO Precision Oncology|January 7, 2022
Reply to M. RatainShing M Lee, Nolan A Wages, Karyn A Goodman, et al.
JCO Precision Oncology|June 21, 2021
Designing Dose-Finding Phase I Clinical Trials: Top 10 Questions That Should Be Discussed With Your StatisticianShing M Lee, Nolan A Wages, Karyn A Goodman, et al.
Clinical Trials (London, England)|November 11, 2005
Methodologic issues in terminating enrollment of a subgroup of patients in a multicenter randomized trialShing M Lee, Robert Wise, Alice L Sternberg, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Journal of Biopharmaceutical Statistics|September 15, 2020
A simulation study of approaches for handling disease progression in dose-finding clinical trialsLucie Biard, Bin Cheng, Gulam A Manji, et al.
Clinical Trials (London, England)|April 9, 2024
Dose optimization for cancer treatments with considerations for late-onset toxicitiesLucie Biard, Anaïs Andrillon, Rebecca B Silva, et al.
Biostatistics (Oxford, England)|November 16, 2017
Dose-finding designs for cumulative toxicities using multiple constraintsShing M Lee, Moreno Ursino, Ying Kuen Cheung, et al.
Journal of Refractive Surgery (Thorofare, N.J. : 1995)|December 7, 2005
The effect of lubricant eye drops on ocular wavefront aberrationsSuzanna Airiani, Joshua Rozell, Shing M Lee, et al.
JCO Precision Oncology|July 12, 2021
Would the Recommended Dose Have Been Different Using Novel Dose-Finding Designs? Comparing Dose-Finding Designs in Published TrialsRebecca B Silva, Christina Yap, Richard Carvajal, et al.
American Journal of Ophthalmology|July 4, 2006
Evaluating central corneal thickness measurements with noncontact optical low-coherence reflectometry and contact ultrasound pachymetrySuzanna Airiani, Stephen L Trokel, Shing M Lee, et al.
Statistics in Medicine|October 31, 2024
Dose Individualization for Phase I Cancer Trials With Broadened EligibilityRebecca B Silva, Bin Cheng, Richard D Carvajal, et al.
JCO Precision Oncology|January 7, 2022
Reply to M. RatainShing M Lee, Nolan A Wages, Karyn A Goodman, et al.
JCO Precision Oncology|June 21, 2021
Designing Dose-Finding Phase I Clinical Trials: Top 10 Questions That Should Be Discussed With Your StatisticianShing M Lee, Nolan A Wages, Karyn A Goodman, et al.
Clinical Trials (London, England)|November 11, 2005
Methodologic issues in terminating enrollment of a subgroup of patients in a multicenter randomized trialShing M Lee, Robert Wise, Alice L Sternberg, et al.
Pageof 7